New spectrophotometric microdetermination of carbapenem antibiotics derivatives in pharmaceutical formulations  by Homoda, Atef M. et al.
Aa
[
a
r
c
r
w
o
e
n
©
t
K
1
p
w
(
P
h
1
CJournal of Taibah University for Science 10 (2016) 19–25
Available  online  at  www.sciencedirect.com
ScienceDirect
New spectrophotometric microdetermination of carbapenem
antibiotics derivatives in pharmaceutical formulations
Atef M. Homoda, Manal S. Kamel, Elmorsy Khaled ∗
Microanalysis Laboratory, National Research Centre, Dokki, Giza 12 622, Egypt
Available online 6 April 2015
bstract
A new sensitive spectrophotometric method was developed to determine three carbapenem antibiotics: imipenem, meropenem
nd ertapenem. The proposed method was based on the formation of the coloured tris(o-phenanthroline)-iron(II) complex (ferroin)
Phen] or Fe (II)-2,2′′-bipyridyl complex [Bip] in the reaction of the tested drugs with the corresponding iron (III)-complexes in
n acetate pH 4 buffer. The formed coloured complexes showed maximum absorbance at 510 and 520 nm for [Phen] and [Bip],
espectively. The reaction conditions, including the pH, reagent concentration, reaction time, temperature and stability of the formed
oloured species, were optimized to achieve the highest sensitivity. Linear calibration curves were obtained in the concentration
anges from 0.2 to 10, 0.5 to 10 and 0.5 to 10 g mL−1 for the aforementioned drugs in the same order. The developed method
as successfully applied to determine the investigated carbapenems in their pharmaceutical formulations with average recoveries
f 100.8, 99.8 and 99.4% for the Phen method and 98.9, 101.7 and 100.6% for the Bip method for imipenem, meropenem and
rtapenem, respectively. A statistical comparison of the results with the reference method showed good concurrence and indicated
o significant difference in accuracy or precision.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Taibah University. This is an open access article under
he CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
eywords: Carbapenem antibiotics; Spectrophotometry; Oxidation reaction; Pharmaceutical analysis.  Introduction
Carbapenems are -lactam antibiotics, such as
enicillins and cephalosporins, that inhibit bacterial cell
all synthesis by binding to penicillin-binding proteinsPBP) [1,2]. The analogues of carbapenem (imipenem,
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yl)amino]ethyl}thio)-7-oxo-1-azabicyclo[3.2.0] hept-2-
ene-2-carboxylic acid}), meropenem, ({3-[5-(dimethyl-
carbamoyl) pyrrolidin-2-yl] sulfanyl-6-(1-hydroxyeth-
yl)-4-methyl-7-oxo-1-azabicyclo[3.2.0] hept-2-ene-2-
carboxylic acid), and ertapenem ({(4R,5S,6S)-3-
[(3S,5S)-5-[(3-carboxyphenyl)carbamoyl]pyrrolidin-3-
yl]sulfanyl-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-aza-
bicyclo[3.2.0]hept-2-ene-2-carboxylic acid}), which
are used in treatment, have an exceptionally broadbehalf of Taibah University. This is an open access article under the
spectrum of antibacterial activity. Since the late
1970s, when thienamycin was discovered, the next
analogues of carbapenem have been introduced into
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em (1)Fig. 1. Chemical structures of imipen
therapeutic use, which include imipenem, panipenem,
meropenem, ertapenem, biapenem and doripenem. The
three carbapenems currently under investigation using
the developed method are imipenem, meropenem and
ertapenem (Fig. 1).
Several analytical techniques were published for car-
bapenem analysis [3]. Currently, the most common
techniques are chromatographic methods [4–8]. In addi-
tion to the chromatographic methods, capillary zone
electrophoresis [9,10] and a microbiological assay [11]
were also reported. The determination of imipenem and
its metabolites in human urine and pharmaceutical for-
mulations using electrochemical methods were reported
[12,13]. The electrochemical protocol was performed in
phosphate buffer solutions over a pH range of 2.0 to 8.0
using differential pulse polarography, cathodic adsorp-
tive stripping voltammetry, cyclic voltammetry, linear
sweep voltammetry and adsorptive stripping voltamme-
try. The proposed methods have been used for the direct
determination of imipenem in spiked human urine and
real human-derived urine with good results and should
be appropriate for monitoring purposes with a detection
limit of 0.28 g L−1 imipenem.
Spectrophotometric methods were also reported for
the determination of carbapenems. Classic UV spec-
trophotometry has been used to estimate meropenem in
powder for injection (wavelength is 298 nm) [14], and
first-derivative bivariate procedures have been applied to
determine meropenem in the presence of its metabolite
(open-ring degradation product) [15]. The UV meth-
ods are notably simple, rapid and economical, and they
enable drug determination with sufficient reliability.
Drug quality control is a branch of analytical
chemistry with a wide impact on public health; thus,
the development of reliable, quick and accurate meth-
ods for active-ingredient determination is notably
important. Spectrophotometric methods are the most
commonly used techniques and continue to enjoy
wide popularity [16–18]. The common availability of
the instrumentation, simplicity of the procedures, and
speed, precision and accuracy of the technique make
spectrophotometric methods attractive. Redox reactions, meropenem (2), and ertapenem (3).
have been used as the basis to develop simple and
sensitive spectrophotometric methods to determine
many pharmaceutical compounds [19–21]. In oxidi-
metric reactions, the most commonly used oxidizing
agents is Fe (III), which reduces to Fe (II), followed by
complexation with either 1,10-phenanthroline [Phen]
or 2,2′′-bipyridyl [Bip] with an absorbance at 510 or
520 nm, respectively. The present study was dedicated
to investigate the application of these reagents in a new
spectrophotometric determination of three carbapenem
derivatives (imipenem, meropenem and ertapenem)
in their pharmaceutical dosage forms. The proposed
methods can be used for quality control analysis, where
modern and expensive apparatuses, such as GLC, HPLC
and HPTLC, are not available.
2.  Experimental
2.1.  Materials  and  reagents
All chemicals were of analytical reagent grade,
and double-distilled water was used throughout the
experiments. The carbapenem pharmaceutical prepa-
ration vials were purchased from the Kingdom
Saudi Arabia local drug stores. The pharmaceutical
preparations were as follows: Tienam (Tienam*-500
imipenem/cilastain sodium, Merck Sharp & Dohme
B.V. Harlem, Netherlands), Meronem (MeronemTM,
meropenem trihydrte 500 mg, Astra Zeneca UK limited,
Macclesfield, Cheshire, Sk 10 2NA, United Kingdom)
and Ertapenem (Invanz®, 1-g vials, BN: NE20790,
labelled to contain 1 g of ertapenem (equivalent to
1.046 g of ertapenem sodium, 175 mg of sodium bicar-
bonate). The concentrations of the corresponding active
ingredients were estimated according to the official
methods [22,24]. Drug stock solutions (100 g m L−1)
were always freshly prepared on the day of analysis and
stored in a refrigerator to be used within 24 h.Fe (III)-o-phenanthroline [Phen] reagent [25] was
prepared by mixing 0.198 g of 1,10-phenanthroline
monohydrate (Fluka, Swiss) with 2.0 mL of 1.0 M HCl
and 0.16 g of ferric ammonium sulphate dodecahydrate
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1Fig. 2. Absorption spectra of Phen and Bip
Fluka, Swiss) and diluting with bidistilled water to
00 mL. The Fe(III)-bipyridyl [Bip] reagent was pre-
ared by dissolving 0.16 g of 2,2′′-bipyridyl in 2.0 mL
f 1.0 M HCl and 0.16 g of ferric ammonium sulphate
odecahydrate and diluting with bidistilled water to
00 mL.
.2.  Apparatus
The preliminary spectrophotometric measurements
ere recorded on a Shimadzu UV-240 spectrophotome-
er (Kyoto, Japan) with 10-mm light-path cells. A JASCO
-570 (Jasco, Japan) double-beam spectrophotometer
Jasco) was used with 10-mm light-path cells for the
bsorbance measurements. The software package that
ccompanied this instrument (Spectra Manager for Win-
ows version 1.21.00) was used for instrument control
nd data handle, whereas the software Spectra Analy-
is version 1.24.00 was used to convert to and save the
pectra as ASCII-typed files. The pH measurements were
erformed with a Metrohm 692 pH-metre using a com-
ined electrode. The measurements were performed in
 double-jacket thermostated glass cell using a Haake
hermosetting circulating water bath with a temperature
tability of 70.0 ±  1.0 ◦C.
.3.  General  procedure
Aliquots of different carbapenem standard solutions
ere transferred into a series of 10-mL calibrated flasksollowed by adding 2 mL of [Phen] or [Bip] reagent solu-
ion and 2.0 mL of a pH 4.00 acetate buffer solution. The
eaction mixture was heated on a water bath at 70 ◦C for
5 min. After cooling to room temperature, the volumexes in presence of 4.0 g mL−1 imipenem.
was diluted to the mark with double-distilled water, and
the formed coloured complexes were measured at 510
and 520 nm for the [Phen] and [Bip] methods, respec-
tively, against a reagent blank, which was similarly
treated. The absorbance values were recorded and plotted
against the drug concentration in g mL−1.
3.  Results  and  discussion
Ferric ions play a prominent role in the spectrophoto-
metric determination of many pharmaceutical drugs by
acting as oxidants, whereas a ferric ion is reduced to a
ferrous ion in extent equivalent to the drug concentration.
The liberated Fe (II) can be determined using selective
chelating agents, such as 1,10-phenanthroline and 2,2-
bipyridyl [26]. The proposed methods are based on the
formation of tris(o-phenanthroline)-iron(II) [Phen] or
tris (bipyridyl)-iron(II) [Bip] chelates upon the reduction
of the corresponding Fe (III) complexes with different
carbapenem derivatives [21,25,27–29] with maximum
absorptions at 510 and 520 nm, respectively (Fig. 2).
Because of the critical role of the reaction conditions on
the analysis performance, comprehensive studies were
performed, for example, the effect of the measured wave-
length, buffer, concentration and sequence of reagent
addition were tested in detail to select the optimal mea-
suring conditions.
3.1.  Effect  of  pHDifferent buffer media, such as universal, phosphate,
borate, and acetate buffer solutions, were examined to
achieve the maximum colour intensity at a fixed car-
bapenem concentration. The acetate buffer proved to be
22 A.M. Homoda et al. / Journal of Taibah University for Science 10 (2016) 19–25
f the [PFig. 3. Effect of pH and reagent concentration on the absorbance o
the most favourable buffer with the highest absorbance
of the formed coloured complexes. A pH adjustment was
necessary, particularly in an acidic medium, because of
the precipitation of ferric ions. The studied pH values
were from 3.0 to 8.0, and the optimum pH value was
4.00 ±  0.20 (Fig. 3a). Moreover, a 2.0 ±  0.1 mL buffer
solution in the reaction medium was sufficient for com-
plete colour development.
3.2.  Effect  of  the  reagent  concentration
Different amounts of Phen or Bip reagents were added
to the reaction mixture, which contained 4 g mL−1 of
imipenium, and the absorbance of the formed coloured
complexes was subsequently measured at 510 and
520 nm, respectively. An addition of 2.0 ±  0.2 mL of
each reagent was sufficient to obtain the maximum
Fig. 4. Effect of temperature and reaction time on the absorbance of [Phhen] and [Bip] complexes in presence of 4.0 g mL−1 Imipenem.
and reproducible absorbance (Fig. 3b). Smaller volumes
of the reagents led to incomplete complex formation,
whereas higher volumes did not improve the method
sensitivity.
3.3.  Effect  of  the  reaction  temperature  and  heating
time
The effects of the temperature and heating time on the
development of the coloured complexes were studied
under the optimal pH and reagent concentration con-
ditions. The reaction of imipenem with both reagents
slowly proceeded at room temperature and was acceler-
ated by heating (Fig. 4). The maximum absorbance was
obtained after heating at 70.0 ±  1.0 ◦C for approximately
15.0 ±  2.0 min. Further heating caused no appreciable
en] and [Bip] complexes in presence of 4.0 g mL−1 Imipenem.
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Table 1
Characteristics of different calibration graph for carbapenem derivatives by developed Phen and Bip methods.
Parameter Units Imipenem Meropenem Ertapenem
Phen Bip Phen Bip Phen Bip
Wavelength (nm) 510 520 510 520 510 520
Beer’s concentration range (g mL−1) 0.2–10.0 0.2–10.0 0.5–10.0 0.5–10.0 0.5–10.0 0.5–10.0
Ringbom concentration range (g mL−1) 0.35–9.5 0.33–9.7 1.05–8.7 1.2–8.8 0.5–9.0 0.52–9.4
Detection limits (g mL−1) 0.064 0.055 0.042 0.074 0.112 0.145
Quantification limits (g mL−1) 0.211 0.176 0.139 0.244 0.358 0.435
Molar absorpitivity ×104 (L mol−1 cm−1) 5.60 3.50 7.00 5.75 8.70 6.58
Sandell sensitivity (g cm −2) 0.0142 0.0128 0.0247 0.01976 0.0227 0.0176
Regression equation (Y = a + bX)a
Slope (b) 0.175 0.114 0.1691 0.13708 0.17315 0.12111
S.D. of slope (Sb) 3.76 × 10−3 2.10 × 10−3 0.00238 0.00339 0.00648 0.00587
Intercept (a) 5.08 × 10−2 2.80 × 10−2 0.05416 0.0346 0.08571 0.08065
S.D. of intercept (Sa) 1.80 × 10−4 1.00 × 10−3 0.0238 0.01785 0.0341 0.03086
Correlation coefficient 0.9984 0.9988 0.9979 0.9982 0.9958 0.9930
Calculated t-values (2.57)b 1.07 0.70 1.10 0.80 1.03 0.74
Calculated F-test (5.05)a 2.37 2.13 2.47 2.22 2.52 2.19
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The proposed spectrophotometric methods have the
advantages that the measurements are performed in the
visible region, away from the UV-absorbing interferinga Y = a + bX, where Y is the absorbance of the coloured complex and
b Values in parentheses are the theoretical values for t- and F-value 
hange in colour. Moreover, the formed coloured com-
lexes were stable for more than 24 h.
.4.  Method  validation
The consistency with Beer’s law was studied by mea-
uring the absorbance values of solutions with various
rug concentrations. The analytical parameters, such
s the molar absorptivity, Sandell’s sensitivity, detec-
ion limit, quantification limit, slope, intercept, and
orrelation coefficients, were described (Table 1). The
alibrations graphs are described by the regression equa-
ion: Y  = a + bX  (where Y  = absorbance, a = intercept,
 = slope and X  = concentration in g mL−1), which was
btained using the method of least squares.
The calibration graphs (Fig. 5) were rectilinear in the
oncentration range of 0.2 to 10 g mL−1, and the molar
bsorptivities were 3.50 ×  104 to 8.70 ×  104. In addi-
ion, a detection limit of 0.042 g mL−1 was obtained
or meropenem using the Phen method.
.5.  Accuracy  and  precision
The accuracy and precision of the methods (within-
ssay and between assays) were determined at different
mipenem concentrations (Table 2). The within-assay
recision was assessed by analysing five replicates of
ach sample as a batch in a single assay run, and the
etween-assays precision was assessed by analysing
he same sample in triplicate in two separate assay
uns. The average recoveries were 95.0–104%, and thee concentration of drug in g mL−1.
confidence limits and five degrees of freedom.
relative standard deviations (RSD) were less than 1.3%
(Table 2). The obtained level of precision was suitable
for the quality control analysis of imipenem.
3.6.  Interference  studies
In pharmaceutical analysis, it is important to test
the selectivity of the method for the excipients that
are commonly added to pharmaceutical preparations,
such as glucose, starch, talc, lactose, and sucrose.Fig. 5. Spectrophotometric determination of imipenem using [Phen]
and [Bip] complexes at the optimum experimental conditions.
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Table 2
Accuracy and precision of the proposed methods for analysis of imipenem (n = 5).
Method Taken (g mL−1) Found (g mL−1)
Within-assays Between-assays
Found (g mL−1) Recovery (%) RDS (%) Found (g mL−1) Recovery (%) RDS (%)
Phen 1.0 0.95 95.00 0.88 0.97 97.00 1.25
3.0 2.86 95.33 0.78 3.12 104.00 0.95
5.0 4.78 95.60 1.10 4.92 98.40 0.98
8.0 7.89 98.63 0.95 7.91 98.88 1.25
Bip 1.0 1.01 101.00 0.65 0.99 99.00 0.66
3.0 3.02 100.66 0.75 2.92 97.33 0.77
5.0 5.10 102.00 1.05 4.85 97.00 0.96
8.0 7.93 99.12 0.82 7.88 98.50 0.74
Table 3
Determination of carbapenem in pharmaceutical preparations by the proposed and official method.
Sample Recovery
Phen Bip Official method
Tienam (500 mg) Recovery 100.8 ± 1.0 Recovery 98.9 ± 1.3 Recovery 99.6 ± 1.3
Variance 0.71 Variance 0.59
F* 2.82 F 2.53
t* 1.93 t 0.55
Meronem (500 mg) Recovery 99.8 ± 0.61 Recovery 101.7 ± 0.92 Recovery 101.0 ± 1.0
Variance 0.55 Variance 0.49
F = 1.74 F 2.03
t = 0.73 t 0.92
Invanz (1.0 g) Recovery 99.4 ± 0.80 Recovery 100.6 ± 0.9 Recovery 100.0 ± 1.4
Variance 0.44 Variance 1.05
F 3.13 
t 0.88 
substances that may be present in the dosage forms.
Regarding the interference of the common excipients
and additives in pharmaceutical formulations (sodium
lauryl sulphate, magnesium stearate, starch sodium gly-
colate, lactose spray dried, carboxymethylcellulose PA
102, talc, titanium dioxide, microcrystalline cellulose,
hydroxypropylcellulose and pre-gelatinized starch), no
change in the absorbance of the formed complex was
observed in the presence of such interferents, which
indicates the high selectivity of the proposed methods.
3.7.  Analytical  applications
The obtained satisfactory validation results made
the proposed methods suitable for the routine quality
control analysis of carbapenem derivatives (imipenem,
ertapenem and meropenem) in their pharmaceutical
preparations. The results of the proposed methods
were statistically compared with those of the officialF 3.05
t 1.22
pharmacopoeia method. The obtained mean values of
the labelled amounts were 98.90 and 101.7% using
the Phen and Bip methods, respectively, as recorded in
Table 3. In the t- and F-tests, no significant difference
was found between the calculated and theoretical values
of both the proposed and reported methods at the 95%
confidence level [22–24]. These results evidently show
that all of the proposed methods can be applied to
analyze different carbapenems in their formulations
with a comparable analytical performance.
4.  Conclusion
The presently proposed method represents simple and
sensitive new spectrophotometric measurements of dif-
ferent carbapenem derivatives in their pharmaceutical
formulations. The redox reaction of carbapenem using
Fe3+ and the formation of Fe2+-Phen and Fe2+-Bip com-
plexes were used to develop a simple, accurate, highly
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